Medifast Inc (NYSE:MED) updated its FY17 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $2.05-$2.15 for the period, compared to the Thomson Reuters consensus estimate of $2.02. The company issued revenue guidance of $290-$300 million, compared to the consensus revenue estimate of $288.65 million.Medifast also updated its Q3 guidance to $0.48-$0.51 EPS.

Separately, Sidoti lowered shares of Medifast from a buy rating to a neutral rating in a research report on Tuesday, May 2nd.

Medifast Inc (MED) traded up 9.25% during trading on Wednesday, hitting $48.30. 213,155 shares of the stock were exchanged. The company has a 50-day moving average price of $41.67 and a 200 day moving average price of $43.10. The firm has a market capitalization of $576.07 million, a price-to-earnings ratio of 29.45 and a beta of 0.48. Medifast Inc has a 1-year low of $34.86 and a 1-year high of $49.11.

Medifast (NYSE:MED) last posted its quarterly earnings results on Tuesday, August 8th. The specialty retailer reported $0.63 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.53 by $0.10. Medifast had a return on equity of 24.94% and a net margin of 7.23%. The business had revenue of $75.70 million during the quarter, compared to the consensus estimate of $71.96 million. During the same period in the prior year, the company posted $0.63 EPS. The firm’s revenue for the quarter was up 6.5% compared to the same quarter last year. Equities analysts predict that Medifast Inc will post $2.02 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 9th. Stockholders of record on Friday, June 23rd will be issued a dividend of $0.32 per share. The ex-dividend date is Wednesday, June 21st. This represents a $1.28 annualized dividend and a dividend yield of 2.90%. Medifast’s dividend payout ratio (DPR) is 77.58%.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/09/medifast-inc-med-releases-fy17-earnings-guidance.html.

About Medifast

Medifast, Inc is engaged in the production, distribution and sale of weight loss, weight management and healthy living products, and other consumable health and nutritional products. Medifast product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products and vitamins.

Receive News & Ratings for Medifast Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifast Inc and related companies with MarketBeat.com's FREE daily email newsletter.